Corticotrophin-releasing activity of desmopressin in Cushing's disease: Lack of correlation between in vivo and in vitro responsiveness

Journal of Endocrinology

Volumn 177, Issue 3, 2003, Pages 373-379

  Pecori Giraldi, F ^b   Marini, E ^b   Torchiana, E ^b   Mortini, P ^a   Dubini, A ^b   Cavagnini, F ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARGIPRESSIN DERIVATIVE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DESMOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR; VASOPRESSIN V3 RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORRELATION FUNCTION; CORTICOTROPIN RELEASE; CUSHING DISEASE; DIFFERENTIAL DIAGNOSIS; DRUG ACTIVITY; FEMALE; GENE EXPRESSION; HORMONE ACTION; HORMONE RESPONSE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; HYPOPHYSIS FUNCTION; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOMA; ADRENOCORTICOTROPIC HORMONE; ADULT; AGED; CORTICOTROPIN-RELEASING HORMONE; CUSHING SYNDROME; DEAMINO ARGININE VASOPRESSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; MALE; MIDDLE AGED; PITUITARY NEOPLASMS; RECEPTORS, VASOPRESSIN; STATISTICS, NONPARAMETRIC; STIMULATION, CHEMICAL; TUMOR CELLS, CULTURED;

EID: 0038039453     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1770373     Document Type: Article

References (33)

1. Abe T, Tachikawa T, Sasaki A, Taniyama M, Okamura Y, Izumiyama H & Matsumoto K 2000 Histopathological and physiological characteristics of cultured human ACTH-secreting cells derived from a rapidly growing pituitary adenoma. Brain Tumor Pathology 17 133-138.
2. Andersson KE, Arner B, Hedner P & Mulder JL 1972 Effects of 8-lysine-vasopressin and synthetic analogues on release of ACTH. Acta Endocrinologica 69 640-648.
3. Antoni FA 1984 Novel ligand specificity of pituitary vasopressin receptors in the rat. Neuroendocrinology 39 186-188.
4. Avgerinos PC, Chrousos GP, Nieman LK, Oldfield EH, Loriaux DL & Cutler GB Jr 1987 The corticotropin-releasing hormone test in the post-operative evaluation of patients with Cushing's syndrome. Journal of Clinical Endocrinology and Metabolism 65 906-913.
5. Buckingham JC 1987 Vasopressin receptors influencing the secretion of ACTH by the rat adenohypophysis. Journal of Endocrinology 113 389-396.
6. Catania A, Cantalamessa L, Orsatti A, Mosca G, Minonzio F, Motta P, Reschini E & Zanussi C 1984 Plasma ACTH response to the corticotropin releasing factor in patients with Cushing's disease. Comparison with the lysine-vasopressin test. Metabolism 33 478-481
7. Coiro V, Volpi R, Capretti L, Caffarri G & Chiodera P 2000 Desmopressin and hexarelin tests in alcohol-induced pseudo-Cushing's syndrome. Journal of Internal Medicine 247 667-673.
8. Colombo P, Passini E, Re T, Faglia G & Ambrosi B 1997 Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess. Clinical Endocrinology 46 661-668.
9. Dahia PLM, Ahmed-Shuaib A, Jacobs RA, Chew SL, Honegger J, Fahlbusch R, Besser GM & Grossman AB 1996 Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors. Journal of Clinical Endocrinology and Metabolism 81 1768-1771.
10. De Keyzer Y, Lenne F, Auzan C, Jégou S, René P, Vaudry H, Kuhn JM, Luton JP, Clauser E & Bertagna X 1996 The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome. Journal of Clinical Investigation 97 1311-1318.
11. De Keyzer Y, René P, Beldjord C, Lenne F & Bertagna X 1998 Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours. Clinical Endocrinology 49 475-482.
12. Dickstein G, de Bold CR, Gaitan D, De Cherney GS, Jackson RV, Sheldon WR, Nicholson WE & Orth DN 1996 Plasma corticotropin and cortisol responses to ovine corticotropin-releasing hormone (CRH), arginine vasopressin (AVP), CRH plus AVP, and CRH plus metyrapone in patients with Cushing's disease. Journal of Clinical Endocrinology and Metabolism 81 2934-2941.
13. Engler D, Redei E & Kola I 1999 The corticotropin-release inhibitory factor hypothesis: a review of the evidence for the existence of inhibitory as well as stimulatory hypophysiotropic regulation of adrenocorticotropin secretion and biosynthesis. Endocrine Reviews 20 460-500.
14. Gaillard RC, Riondel AM, Ling N & Muller AF 1988 Corticotropin releasing factor activity of CRF-41 in normal man is potentiated by angiotensin II and vasopressin but not by desmopressin. Life Sciences 43 1935-1944.
15. Hedge GA, Yates MB, Marcus R & Yates FE 1966 Site of action of vasopressin causing corticotropin release. Endocrinology 79 328-340.
16. Invitti C, Pecori Giraldi F, De Martin M, Cavagnini F & The Study Group of the Italian Society of Endocrinology on the Pathophysiology of the Hypothalamic-Pituitary-Adrenal Axis 1999a Diagnosis and management of Cushing's syndrome: results of an Italian multicentre study. Journal of Clinical Endocrinology and Metabolism 84 440-448.
17. Invitti C, Pecori Giraldi F, Dubini A, Moroni P, Losa M, Piccoletti R & Cavagnini F 1999b Galanin is released by adrenocorticotropin-secreting pituitary adenomas in vivo and in vitro. Journal of Clinical Endocrinology and Metabolism 84 1351-1356.
18. Jessop DS 1999 Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. Journal of Endocrinology 160 169-180.
19. Kjær A, Knigge U, Bach FW & Warberg J 1992 Histamine- and stress-induced secretion of ACTH and β-endorphin: involvement of corticotropin-releasing hormone. Neuroendocrinology 36 419-428.
20. Knepel W, Homolka L, Vlaskovska M & Nutto D 1984 In vitro adrenocorticotropin/β-endorphin-releasing activity of vasopressin analogs is related neither to pressor nor to antidiuretic activity. Endocrinology 114 1797-1804.
21. Legros JJ 2001 Inhibitory effect of oxytocin on corticotrope function in humans: are vasopressin and oxytocin ying-yang neurohormones? Psychoneuroendocrinology 26 649-655.
22. Liu JH, Muse K, Contreras P, Gibbs D, Vale WW, Rivier J & Yen SSC 1983 Augmentation of ACTH-releasing activity of synthetic corticotropin releasing factor (CRF) by vasopressin in women. Journal of Clinical Endocrinology and Metabolism 57 1087-1089.
23. Lolait SJ, O'Carroll AM, Mahan LC, Felder CC, Button DC, Young WS, Mezey E & Brownstein MJ 1995 Extrapituitary expression of the rat V1b vasopressin receptor gene. PNAS 92 6783-6787.
24. Malerbi DA, Mendonça BB, Liberman B, Toledo SPA, Corradini MCM, Cunha-Neto MB, Fragoso MCBV & Wajchenberg BL 1993 The desmopressin stimulation test in the differential diagnosis of Cushing's syndrome. Clinical Endocrinology 38 463-472.
25. Malerbi DA, Fragoso MCBV, Vieira Filho AHG, Brenlha EML & Mendonça BB 1996 Cortisol and adrenocorticotropin response to desmopressin in women with Cushing's disease compared with depressive illness. Journal of Clinical Endocrinology and Metabolism 81 2233-2237.
26. Moro M, Putignano P, Losa M, Invitti C, Maraschini C & Cavagnini F 2000 The desmopressin test in the differential diagnosis between Cushing's disease and pseudoCushing states. Journal of Clinical Endocrinology and Metabolism 85 3569-3574.
27. Pecori Giraldi F & Cavagnini F 1998 Corticotropin-releasing hormone is produced by rat corticotropes and modulates ACTH secretion in a paracrine/autocrine fashion. Journal of Clinical Investigation 101 2478-2484.
28. Plotsky PM, Bruhn TO & Vale WW 1984 Central modulation of immunoreactive corticotropin-releasing factor secretion by arginine vasopressin. Endocrinology 115 1639-1641.
29. Putignano, P, Moro M, Pecori Giraldi F, Invitti C & Cavagnini F 1999 Stimulation by CRH and DDAVP in patients with Cushing's disease and normal subjects. Effect of basal cortisol and ACTH levels. 6th International Pituitary Congress, Long Beach, CA, USA. 81 (Abstract).
30. Rivier C & Vale WW 1983 Interaction of corticotropin-releasing factor and arginine vasopressin on adrenocorticotropin secretion in vivo. Endocrinology 113 939-942.
31. Sakai Y, Horiba N, Tozawa F, Sakai K, Kuwayama A, Demura H & Suda T 1997 Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing's syndrome. Endocrine Journal 44 687-695.
32. Thibonnier M, Conarty DM, Preston JA, Wilkins PL, Berti-Mattera L & Mattera R 1998 Molecular pharmacology of human vasopressin receptors. Advances in Experimental Medicine and Biology 449 251-276.
33. Tsagarakis S, Vasiliou V, Kokkoris P, Stavropoulos G & Thalassinos N 1999 Assessment of cortisol and ACTH responses to the desmopressin test in patients with Cushing's syndrome and simple obesity. Clinical Endocrinology 51 473-477.